21-200-319

Roche Diagnostics cobas™ Liat SARS-CoV-2, Influenza A/B and RSV RT-PCR Assay Kit

Manufacturer: Roche Diagnostics

Select a Size

Pack Size SKU Availability Price
Each of 1 21-200-319-Each-of-1 In Stock ₹ 2,21,087.04

21-200-319 - Each of 1

₹ 2,21,087.04

In Stock

Quantity

1

Base Price: ₹ 2,21,087.04

GST (18%): ₹ 39,795.667

Total Price: ₹ 2,60,882.707

Content And Storage

3 sets of positive and negative controls per kit

CPT Code

87637 (for assay)

Clia Complexity

Waived (EUA)

Detection Method

RT-PCR

Format

Kit

Sensitivity

For assay: Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement

Disposable

Single-use

For Use With (Equipment)

Used with the cobas™ liat analyzer to validate lots or run control tests

Quantity

1

Analysis Time

20 min.

Weight (English)

0.1 lb.

Control Sets

integrated sample processing control, positive and negative controls

CE Marker

Yes

Detectable Analytes

SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies

DoA Calibrators

No

Sample Type

For assay: nasaopharyngeal or anterior nasal

Type

Control

For Use With (Application)

Detection of SARS-CoV-2, Influenza A/B, and RSV

Product Line

cobas™

Specificity

For assay: SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement

Dimensions (L x W x H)

6.1 x 10 x 1.4 in.

Form

Ready-to-Use (RTU)

Related Products

Img

Roche Diagnostics

21-200-318

--

Img

Roche Diagnostics

23-312-207

--

Img

Roche Diagnostics

23-312-200

--

Img

Germaine™ Laboratories

23-111-441

--

Img

Roche Diagnostics

23-312-208

--

Img

Germaine™ Laboratories

23-900-207

--

Img

Fischer Scientific

23-999-117

--

Img

Fischer Scientific

23-999-116

--

Description

  • The cobas™ liat SARS-CoV-2, Influenza A/B and RSV Nucleic acid test for use on the cobas™ Liat™ System is an automated rapid multiplex real-time, reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the simultaneous qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A, and influenza B virus, and respiratory syncytial virus nucleic acid in nasopharyngeal swab (NPS) and anterior nasal swab (ANS) specimens from individuals with signs and symptoms of respiratory tract infection
  • This test has no age restrictions

SAFETY INFORMATION

  • ShelfLife : 12 Months